Clinical cancer genomics: how soon is now?TAYLOR, Barry S; LADANYI, Marc.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 318-326, issn 0022-3417, 9 p.Article

Cancer Biology and GenomicsLADANYI, Marc; HOGENDOORN, Pancras CW.Journal of pathology (Print). 2011, Vol 223, Num 2, issn 0022-3417, 228 p.Serial Issue

Fusions of the SYT and SSX genes in synovial sarcomaLADANYI, Marc.Oncogene (Basingstoke). 2001, Vol 20, Num 40, pp 5755-5762, issn 0950-9232Article

Tracing the origins of metastasisNGUYEN, Don X.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 195-204, issn 0022-3417, 10 p.Article

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysisRONGLAI SHEN; OLSHEN, Adam B; LADANYI, Marc et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 22, pp 2906-2912, issn 1367-4803, 7 p.Article

The GIST paradigm: lessons for other kinase-driven cancersANTONESCU, Cristina R.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 251-261, issn 0022-3417, 11 p.Article

SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug : A potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcomaSAITO, Tsuyoshi; NAGAI, Makoto; LADANYI, Marc et al.Cancer research (Baltimore). 2006, Vol 66, Num 14, pp 6919-6927, issn 0008-5472, 9 p.Article

Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomasARGANI, Pedram; LADANYI, Marc.Pathology (Sydney). 2003, Vol 35, Num 6, pp 492-498, issn 0031-3025, 7 p.Article

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysisSHEN, Ronglai; OLSHEN, Adam B; LADANYI, Marc et al.Bioinformatics (Oxford. Print). 2010, Vol 26, Num 2, pp 292-293, issn 1367-4803, 2 p.Article

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitorsBREVET, Marie; JOHNSON, Melissa L; AZZOLI, Christopher G et al.Lung cancer. 2011, Vol 73, Num 1, pp 96-102, issn 0169-5002, 7 p.Article

The molecular pathology of breast cancer progressionBOMBONATI, Alessandro; SGROI, Dennis C.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 307-317, issn 0022-3417, 11 p.Article

The dynamic roles of TGF-β in cancerMEULMEESTER, Erik; TEN DIJKE, Peter.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 205-218, issn 0022-3417, 14 p.Article

KRAS and BRAF: drug targets and predictive biomarkersVAKIANI, Efsevia; SOLIT, David B.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 219-229, issn 0022-3417, 11 p.Article

The molecular background of aggressive B cell lymphomas as a basis for targeted therapyDE JONG, Daphne; BALAGUE PONZ, Olga.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 274-282, issn 0022-3417, 9 p.Article

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmidsLOPEZ-RIOS, Fernando; ILLEI, Peter B; RUSCH, Valerie et al.Lancet (British edition). 2004, Vol 364, Num 9440, pp 1157-1166, issn 0140-6736, 10 p.Article

Glioneuronal tumor with neuropil-like islands (GTNI) : A report of 8 cases with chromosome 1 p/19q deletion analysisBARBASHINA, Violetta; SALAZAR, Paulo; LADANYI, Marc et al.The American journal of surgical pathology. 2007, Vol 31, Num 8, pp 1196-1202, issn 0147-5185, 7 p.Article

The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomasLAFLAMME, Cynthia; FILION, Christine; BRIDGE, Julia A et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 449-454, issn 0008-5472, 6 p.Article

Melanotic Xp11 Translocation Renal Cancers : A Distinctive Neoplasm With Overlapping Features of PEComa, Carcinoma, and MelanomaARGANI, Pedram; AULMANN, Sebastian; KARANJAWALA, Zarir et al.The American journal of surgical pathology. 2009, Vol 33, Num 4, pp 609-619, issn 0147-5185, 11 p.Article

EWS-CREB1 : A recurrent variant fusion in clear cell sarcoma- association with gastrointestinal location and absence of melanocytic differentiationANTONESCU, Cristina R; NAFA, Khedoudja; SEGAL, Neil H et al.Clinical cancer research. 2006, Vol 12, Num 18, pp 5356-5362, issn 1078-0432, 7 p.Article

Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineageSHUN JIANG YU; LEI ZHENG; LADANYI, Marc et al.Clinical cancer research. 2004, Vol 10, Num 19, pp 6750-6758, issn 1078-0432, 9 p.Article

Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assayARGANI, Pedram; LAL, Priti; HUTCHINSON, Brian et al.The American journal of surgical pathology. 2003, Vol 27, Num 6, pp 750-761, issn 0147-5185, 12 p.Article

The role of mutant p53 in human cancerGOH, Amanda M; COFFILL, Cynthia R; LANE, David P et al.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 116-126, issn 0022-3417, 11 p.Article

Genetically informed lung cancer medicinePAO, William; LAFRATE, A. John; ZENGLIU SU et al.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 230-240, issn 0022-3417, 11 p.Article

A new era: melanoma genetics and therapeuticsKO, Justin M; FISHER, David E.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 241-250, issn 0022-3417, 10 p.Article

HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoringLAL, Priti; SALAZAR, Paulo A; HUDIS, Clifford A et al.American journal of clinical pathology. 2004, Vol 121, Num 5, pp 631-636, issn 0002-9173, 6 p.Article